Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,490.00
-130.00 (-3.59%)
At close: Mar 27, 2026
Market Cap53.49B -23.4%
Revenue (ttm)201.20B +12.4%
Net Income-605.35M
EPS-40.00
Shares Out15.33M
PE Ration/a
Forward PEn/a
Dividend75.00 (2.24%)
Ex-Dividend DateDec 29, 2025
Volume72,396
Average Volume60,694
Open3,585.00
Previous Close3,620.00
Day's Range3,465.00 - 3,645.00
52-Week Range3,120.00 - 5,760.00
Beta0.42
RSI47.89
Earnings Daten/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements